The Patent Finder

Terms ending in 2029

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,988,459ANTI-IFNAR1 Antibodies with Reduced FC Ligand Affinity
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,301,390ANTI-IFNAR1 Antibodies with Reduced FC Ligand Affinity
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,813,246Pharmaceutical Composition
In force
 · Medium confidence
Alexion Pharma International Operations LimitedIn forceMedium confidence
US 12,220,403Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 12,318,367Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 12,364,684Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 8,616,196Inhalation Device and a Method for Assembling Said Inhalation Device
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 7,425,637N3 Alkylated Benzimidazole Derivatives as Mek Inhibitors
In force
 · High confidence
Alexion Pharma International Operations LimitedIn forceHigh confidence
US 7,960,3955,7-Disubstituted Thiazolo[4,5-d]pyrimidines for the Selective Inhibition of Chemokine Receptors
In force
 · High confidence
Kancera ABIn forceHigh confidence
US 7,842,803Nicotinic Acetylcholine Receptor Ligands 101
In force
 · High confidence
Acturum Life ABIn forceHigh confidence
15 more term ends in 2029 · Pro
10 of 25 patents shown. Soonest term end first, then patent number.
Pro members see all 25.
Upgrade to Pro
11 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited